In March 2025, the company announced new ideas for a direct-to-client supplying of its Wegovy weight loss drug. The company proven a brand new pharmacy, identified as NovoCare, which might demand clients $499 per 30 days for usage of the drug, a lot less than fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[f
A Secret Weapon For who makes copyright
U.S. pharma giant copyright scrapped two experimental weight loss tablets last yr—a at the time-everyday pill, lotiglipron, because of elevated liver enzymes plus a two times-day-to-day tablet, danuglipron, resulting from solid Unwanted side effects—but CEO Albert Bourla has claimed the company is set to “play and win” from the obesity Room